Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 38 Neoplasms 22 Motor Activity 12 Colorectal Neoplasms 9 Lung Neoplasms 8 Stomach Neoplasms 7 Pain, Postoperative 7 Fatigue 7 Anxiety Disorders 6 Pain 5 Carcinoma, Hepatocellular 5 Rectal Neoplasms 4 Polycystic Ovary Syndrome 4 Leukemia, Myeloid, Acute 4 Depression 4 Colonic Neoplasms 4 Thyroid Neoplasms 3 Stomatitis 3 Squamous Cell Carcinoma of Head and Neck 3 Sleep Initiation and Maintenance Disorders 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Malnutrition 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Agnosia 3 Vomiting 2 Uterine Cervical Neoplasms 2 Urinary Incontinence 2

Interventions

Etoposide 30 Carboplatin 30 Cisplatin 23 Ifosfamide 22 Filgrastim 22 Paclitaxel 18 Peripheral Blood Stem Cell Transplantation 16 Bleomycin 13 Cyclophosphamide 11 Radiotherapy 8 Thiotepa 7 Magnetic Resonance Spectroscopy 6 Gemcitabine 6 pegfilgrastim 5 Therapeutics 5 Melphalan 5 Granulocyte Colony-Stimulating Factor 5 Busulfan 5 etoposide phosphate 4 Temozolomide 4 Oxaliplatin 4 Dexamethasone 4 sargramostim 3 Vinblastine 3 Taxes 3 Psychiatric Rehabilitation 3 Polymerase Chain Reaction 3 Methylprednisolone 3 Methods 3 Immunohistochemistry 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Testicular Neoplasms × Control Groups × Clear all

NCT02577172 2017-01-26

TAST

Oslo University Hospital

Phase NA Terminated

Motor Activity, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡